Drugs (psychoactive) - World Health Organization (WHO) Psychoactive drugs are substances that, when taken in or administered into one's system, affect mental processes, e g cognition or affect This term and its equivalent, psychotropic drug, are the most neutral and descriptive term for the whole class of substances, licit and illicit, of interest to drug policy
WHO Drug Information - World Health Organization (WHO) About WHO Drug Information WHO Drug Information is a quarterly journal providing an overview of topics relating to medicines development and regulation which is targeted to a wide audience of health professionals and policy makers
UN Commission approves WHO recommendations to place psychoactive . . . “We are pleased that the Commission (on Narcotic Drugs) has accepted the full set of WHO recommendations and added these substances to relevant schedules in the 1961 or 1971 Conventions We hope countries and communities will increase vigilance and take necessary actions to protect vulnerable groups particularly youth from these substances ”
Alcohol, Drugs and Addictive Behaviours - World Health Organization (WHO) Alcohol, Drugs and Addictive Behaviours The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence-informed policies, strategies and interventions to reduce the burden associated with alcohol, drugs and addictive behaviours
COVID-19 Treatments - World Health Organization (WHO) Thousands of trials investigating COVID-19 interventions have been registered or are ongoing WHO, through its COVID-19 Solidarity Therapeutics Trial, is coordinating global efforts to find drugs and other therapies that can save lives for those with severe or critical COVID-19
Medicines - World Health Organization (WHO) Today there are thousands of drugs on the market able to prevent, treat and lessen the impact of ailments that would have been fatal just a few generations ago At the same time, antimicrobial resistance is challenging the effectiveness of many commonly used medicines in one of the most concerning threats to global health today
Guidelines for HIV post-exposure prophylaxis WHO’s updated PEP guidelines prioritize broader access to PEP, including community-based delivery and task sharing to mitigate barriers such as stigma and to ensure timely access post exposure PEP involves administering antiretroviral (ARV) medication after potential HIV exposure to prevent infection
Health products policy and standards - World Health Organization (WHO) Nonproprietary names are intended for use in pharmacopoeias, labelling, product information, advertising and other promotional material, drug regulation and scientific literature, and as a basis for product names, e g for generics
Anatomical Therapeutic Chemical (ATC) Classification Such drugs are usually only given one code and this may be a problem for users in countries where other uses are predominant Medicinal products containing two or more active ingredients are regarded as combinations in the ATC classification system and given different ATC codes from the product with a single component (one active ingredient)